Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer

Clinical Cancer Research

Volumn 6, Issue 8, 2000, Pages 3183-3192

  Janssen, A Miranda L ^a   Bosman, Coen B ^a   Van Duijn, Wim ^a   Oostendorp van De Ruit, Marjan M ^a   Kubben, Frank J G M ^a   Griffioen, Gerrit ^a   Lamers, Cornelis B H W ^a   Van Krieken, J Han J M ^a   Van De Velde, Cornelis J H ^a   Verspaget, Hein W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; COLORECTAL CANCER; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; TISSUE LEVEL; TUMOR PROMOTION;

ADENOCARCINOMA; AGED; COPPER; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MANGANESE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; SUPEROXIDE DISMUTASE; SURVIVAL ANALYSIS; ZINC;

EID: 0033900975     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. McCord, J. M., and Fridovich, I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem., 244: 6049-6055, 1969.
2. Fridovich, I. Superoxide dismutases. Annu. Rev. Biochem., 44: 147-159, 1975.
3. Farber, J. L., Kyle, M. E., and Coleman, J. B. Biology of disease. Mechanisms of cell injury by activated oxygen species. Lab. Invest., 62: 670-679, 1990.
4. Beyer, W., Imlay, J., and Fridovich, I. Superoxide dismutases. Prog. Nucleic Acid Res. Mol. Biol., 40: 221-253, 1991.
5. Sahu, S. C. Role of oxygen free radicals in the molecular mechanisms of carcinogenesis: a review. J. Environ. Sci. Health, C9: 83-112, 1991.
6. Slater, T. F. Free-radical mechanisms in tissue injury. Biochem. J., 222: 1-15, 1984.
7. Borek, C. Radiation and chemically induced transformation: free radicals, antioxidants and cancer. Br. J Cancer, 55 (Suppl. 8): 74-86, 1987.
8. Guyton, K. Z., and Kensler, T. W. Oxidative mechanisms in carcinogenesis. Br. Med. Bull., 49: 523-544, 1993.
9. Farber, J. L. Mechanisms of cell injury by activated oxygen species. Environ. Health Perspect., 102 (Suppl. 10): 17-24, 1994.
10. Wiseman, H., and Halliwell, B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J., 313: 17-29, 1996.
11. Oberley, L. W., and Buettner, G. R. Role of superoxide dismutase in cancer: a review. Cancer Res., 39: 1141-1149, 1979.
12. Petkau, A. Role of superoxide dismutase in modification of radiation injury. Br. J. Cancer, 55 (Suppl. 8): 87-95, 1987.
13. Oberley, L. Free radical biology: a paradox in cancer research. J. Natl. Cancer Inst., 82: 902-903, 1990.
14. Sangeetha, P., Das, U. N., Koratkar, R., and Suryaprabha, P. Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic. Biol. Med., 8: 15-19, 1990.
15. Oury, T. D., Chang, L-L., Marklund, S. L., Day, B. J., and Crapo, J. D. Immunocytochemical localization of extracellular superoxide dismutase in human lung. Lab. Invest., 70: 889-898, 1994.
16. Janssen, A. M. L., Bosman, C. B., Kruidenier, L., Griffioen, G., Lamers, C. B. H. W., van Krieken, J. H. J. M., van de Velde, C. J. H., and Verspaget, H. W. Superoxide dismutases in the human colorectal cancer sequence. J. Cancer Res. Clin. Oncol., 125: 327-335, 1999.
17. Janssen, A. M. L., Bosman, C. B., Sier, C. F. M., Griffioen, G., Kubben, F. J. G. M., Lamers, C. B. H. W., van Krieken, J. H. J. M., van de Velde, C. J. H., and Verspaget, H. W. Superoxide dismutases in relation to the overall survival of colorectal cancer patients. Br. J. Cancer, 78: 1051-1057, 1998.
18. Izutani, R., Katoh, M., Asano, S., Ohyanagi, H., and Hirose, K. Enhanced expression of manganese superoxide dismutase mRNA and increased TNFα mRNA expression by gastric mucosa in gastric cancer. World J. Surg., 20: 228-233, 1996.
19. Izutani, R., Asano, S., Imano, M., Kuroda, D., Kato, M., and Ohyanagi, H. Expression of manganese superoxide dismutase in esophageal and gastric cancers. J. Gastroenterol., 33: 816-822, 1998.
20. Hermanek, P., and Sobin, L. H. UICC TNM Classification of Malignant Tumors, Ed. 4. London: Springer, 1992.
21. Laurén, P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol. Microbiol. Scand., 64: 31-49, 1965.
22. Mulder, T. P. J., Verspaget, H. W., Janssens, A. R, de Bruin, P. A. F., Griffioen, G., and Lamers, C. B. H. W. Neoplasia related changes of two copper (Cu)/zinc (Zn) proteins in the human colon. Free Radic. Biol. Med., 10: 501-506, 1990.
23. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. Protein measurement with the folin phenol reagent. J. Biol. Chem., 193: 265-275, 1951.
24. Götz, J. M., van Kan, C. I., Verspaget, H. W., Biemond, I., Lamers, C. B. H. W., and Veenendaal, R. A. Gastric mucosal superoxide dismutases in Helicobacter pylori infection. Gut, 38: 502-506, 1996.
25. Cox, D. R. Regression models and life-tables. Mathematics: Journal of the Royal Statistical Society, 34: 187-220, 1972.
26. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
27. Oberley, T. D., and Oberley, L. W. Antioxidant enzyme levels in cancer. Histol. Histopathol., 12: 525-535, 1997.
28. Sun, Y. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic. Biol. Med., 8: 583-599, 1990.
29. Beño, I., Staruchová, M., Volkovová, K., and Bátovský, M. Increased antioxidant enzyme activities in the colorectal adenoma and carcinoma. Neoplasma, 42: 265-269, 1995.
30. Satomi, A., Murakami, S., Hashimoto, T., Ishida, K., Matsuki, M., and Sonoda, M. Significance of superoxide dismutase (SOD) in human colorectal cancer tissue: correlation with malignant intensity. J. Gastroenterol., 30: 177-182, 1995.
31. Yang, A. H., Oberley, T. D., Oberley, L. W., Schmid, S. M., and Cummings, K. B. In vitro modulation of antioxidant enzymes in normal and malignant renal epithelium. In Vitro Cell. Dev. Biol., 23: 546-558, 1987.
32. Iizuka, S., Taniguchi, N., and Makita, A. Enzyme-linked immunosorbent assay for human manganese-containing superoxide dismutase and its content in lung cancer. J. Natl. Cancer Inst., 72: 1043-1049, 1984.
33. Ishikawa, M., Yaginuma, Y., Hayashi, H., Shimizu, T., Endo, Y., and Taniguchi, N. Reactivity of a monoclonal antibody to manganese superoxide dismutase with human ovarian carcinoma. Cancer Res., 50: 2538-2542, 1990.
34. Oberley, T. D., Sempf, J. M., Oberley, M. J., McCormick, M. L., Muse, K. E., and Oberley, L. W. Immunogold analysis of antioxidant enzymes in human renal cell carcinoma. Virchows Arch., 424: 155-164, 1994.
35. Schadendorf, D., Zuberbier, T., Diehl, S., Schadendorf, C., and Czarnetzki, B. M. Serum manganese superoxide dismutase is a new tumor marker for malignant melanoma. Melanoma Res., 5: 351-353, 1995.
36. Landriscina, M., Remiddi, F., Ria, F., Palazzotti, B., De Leo, M. E., Iacoangeli, M., Rosselli, R., Scerrati, M., and Galeotti, T. The level of MnSOD is directly correlated with grade of brain tumours of neuroepithelial origin. Br. J. Cancer, 74: 1877-1885, 1996.
37. Coursin, D. B., Cihla, H. P., Sempf, J., Oberley, T. D., and Oberley, L. W. An immunohistochemical analysis of antioxidant and glutathione S-transferase enzyme levels in normal and neoplastic human lung. Histol. Histopathol., 11: 851-860, 1997.
38. Hassan, H. M. Biosynthesis and regulation of superoxide dismutases. Free Radic. Biol. Med., 5: 377-385, 1988.
39. Touati, D. Molecular genetics of superoxide dismutases. Free Radic. Biol. Med., 5: 393-402, 1988.
40. Qureshi, A., Gorey, T. F., Byrne, P., Kay, E., McKeever, J., and Hennessy, T. P. J. Oxygen free radical activity in experimental colonic carcinoma. Br. J. Surg., 81: 1058-1059, 1994.
41. Warner, B. B., Stuart, L., Gebb, S., and Wispé, J. R. Redox regulation of manganese superoxide dismutase. Am. J. Physiol., 271: L150-L158, 1996.
42. Wong, G. H. W., and Goeddel, D. V. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science (Washington DC), 242: 941-944, 1988.
43. Visner, G. A., Dougall, W. C., Wilson, J. M., Burr, I. A., and Nick, H. S. Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response. J. Biol. Chem., 265: 2856-2864, 1990.
44. Valentine, J. F., and Nick, H. S. Acute-phase induction of manganese superoxide dismutase in intestinal epithelial cell lines. Gastroenterology, 103: 905-912, 1992.
45. Yoshimi, N., Sato, S., Makita, H., Wang, A., Hirose, Y., Tanaka, T., and Mori, H. Expression of cytokines, TNF-α and IL-1α, in MAM acetate and 1-hydroxyanthraquinone-induced colon carcinogenesis of rats. Carcinogenesis (Lond.), 15: 783-785, 1994.
46. St. Clair, D. K., Oberley, T. D., Muse, K. E., and St. Clair, W. H. Expression of manganese superoxide dismutase promotes cellular differentiation. Free Radic. Biol. Med., 16: 275-282, 1994.
47. Kiningham, K. K., and St. Clair, D. K. Overexpression of manganese superoxide dismutase selectively modulates the activity of junassociated transcription factors in fibrosarcoma cells. Cancer Res., 57: 5265-5271, 1997.
48. Beyer, Jr. J. F., and Fridovich, I. Assaying for superoxide dismutase activity: some large consequences of minor changes in conditions. Anal. Biochem., 161: 559-566, 1987.
49. Weber, G. F. The measurement of oxygen-derived free radicals and related substances in medicine. J. Clin. Chem. Clin. Biochem., 28: 569-603, 1990.
50. Allum, W. H., Powell, D. J., McConkey, C. C., and Fielding, J. W. L. Gastric cancer: a 25-year review. Br. J. Surg., 76: 535-540, 1989.
51. Rohde, H., Gebbensleben, B., Bauer, P., Stützer, H., and Zieschang, J. Has there been any improvement in the staging of gastric cancer. Cancer (Phila.), 64: 2465-2481, 1989.
52. Nakamura, K., Ueyama, T., Yao, T., Xuan, Z. X., Ambe, K., Adachi, Y., Yakeishi, Y., Matsukuma, A., and Enjoji, M. Pathology and prognosis of gastric carcinoma. Cancer (Phila.), 70: 1030-1037, 1992.
53. Roder, J. D., Böttcher, K., Siewert, J. R., Busch, R., Hermanek, P., and Meyer, H. J. Prognostic factors in gastric carcinoma. Cancer (Phila.), 72: 2089-2097, 1993.
54. Fuch, C. S., and Mayer, R. J. Gastric carcinoma. N. Engl. J. Med., 333: 32-41, 1995.
55. Kwon, S. J., and Kim, G. S. Prognostic significance of lymph node metastasis in advanced carcinoma of the stomach. Br. J. Surg., 83: 1600-1603, 1996.
56. Iwasaki, K., Torisu, M., and Fujimura, T. Malignant tumor and eosinophils. I. Prognostic significance in gastric cancer. Cancer (Phila.), 58: 1321-1327, 1986.
57. Yu, C. C. W., Levison, D. A., Dunn, J. A., Ward, L. C., Demonakou, M., Allum, W. H., and Hallisey, M. T. Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer. Br. J. Cancer, 71: 1106-1110, 1995.
58. Songun, I., van de Velde, C. J. H., Hermans, J., Pals, S. T., Verspaget, H. W., Vis, A. N., Menon, A. G., Litvinov, S. V., and van Krieken, J. H. J. M. Expression of oncoproteins and the amount of eosinophilic and lymphocytic infiltrates can be used as prognostic factors in gastric cancer. Br. J. Cancer, 74: 1783-1788, 1996.
59. Pretlow, T. P., Keith, E. F., Cryar, A. K., Bartolucci, A. A., Pitts, A. M., Pretlow, II. T. G., Kimball, P. M., and Boohaker, E. A. Eosinophil infiltration of human colonic carcinomas as a prognostic indicator. Cancer Res., 43: 2997-3000, 1983.
60. Ganesh, S., Sier, C. F. M., Heerding, M. M., van Krieken, J. H. J. M., Griffioen, G., Welvaart, K., van de Velde, C. J. H., Verheijen, J. H., Lamers, C. B. H. W., and Verspaget, H. W. Prognostic value of the plasminogen activation system in patients with gastric carcinoma. Cancer (Phila.), 77: 1035-1043, 1996.
61. Sier, C. F. M., Kubben, F. J. G. M., Ganesh, S., Heerding, M. M., Griffioen, G., Hanemaaijer, R., van Krieken, J. H. J. M., Lamers, C. B. H. W., and Verspaget, H. W. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br. J. Cancer, 74: 413-417, 1996.
62. Shibanuma, M., Kuroki, T., and Nose, K. Induction of DNA replication and expression of proto-oncogene c-myc and c-fos in quiescent Balb/3T3 cells by xanthine/xanthine oxidase. Oncogene, 3: 17-21, 1988.
63. Murrell, G. A. C., Francis, M. J. O., and Bromley, L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem. J., 265: 659-665, 1990.
64. Shibanuma, M., Kuroki, T., and Nose, K. Stimulation by hydrogen peroxide of DNA synthesis, competence family gene expression and phosphorylation of a specific protein in quiescent Balb/3T3 cells. Oncogene, 5: 1025-1032, 1990.
65. Burdon, R. H., Gill, V., and Alliangana, D. Hydrogen peroxide in relation to proliferation and apoptosis in BHK-21 hamster fibroblasts. Free Radic. Res., 24: 81-93, 1996.
66. Crawford, D., Zbinden, I., Amstad, P., and Cerutti, P. Oxidant stress induces the proto-oncogenes c-fos and c-myc in mouse epidermal cells. Oncogene, 3: 27-32, 1988.
67. Li, J-J., Oberley, L. W., Fan, M., and Colburn, N. H. Inhibition of AP-1 and NF-κB by manganese-containing superoxide dismutase in human breast cancer cells. FASEB J., 12: 1713-1723, 1998.
68. Manna, S. K., Zhang, H. J., Yan, T., Oberley, L. W., and Aggarwal, B. B. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-κB and activated protein-1. J. Biol. Chem., 273: 13245-13524, 1998.
69. Cerutti, P. A. Pro-oxidant states and tumor promotion. Science (Washington DC), 227: 375-381, 1985.
70. Dreher, D., and Junod, A. F. Role of oxygen free radicals in cancer development. Eur. J. Cancer, 32A: 30-38, 1996.
71. Correa, P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res., 52: 6735-6740, 1992.
72. Götz, J. M., Thio, J. L., Verspaget, H. W., Offerhaus, G. J. A., Biemond, I., Lamers, C. B. H. W., and Veenendaal, R. A. Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dimutases. Gut, 40: 591-596, 1997.
73. Mooney, C., Keenan, J., Munster, D., Wilson, I., Allardyce, R., Bagshaw, P., Chapman, B., and Chadwick, V. Neutrophil activation by Helicobacter pylori. Gut, 32: 853-857, 1991.
74. Davies, G. R., Simmonds, N. J., Stevens, T. R. J., Sheaff, M. T., Banatvala, N., Laurenson, I. F., Blake, D. R., and Rampton, D. S. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut, 35: 179-185, 1994.
75. Baik, S-C., Youn, H-S., Chung, M-H., Lee, W-K., Cho, M-J., Ko, G-H., Park, C-K., Kasai, H., and Rhee, K-H. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res., 56: 1279-1282, 1996.
76. Farinati, F., Cardin, R., Degan, P., Rugge, M., Di Mario, F., Bonvicini, P., and Naccarato, R. Oxidative DNA damage accumulation in gastric carcinogenesis. Gut, 42: 351-356, 1998.
77. Ambrosone, C. B., Freudenheim, J. L., Thompson, P. A., Bowman, E., Vena, J. E., Marshall, J. R., Graham, S., Laughlin, R., Nemoto, T., and Shields, P. G. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res., 59: 602-606, 1999.